Financials data is unavailable for this security.
View more
Year on year Mankind Pharma Ltd grew revenues 18.12% from 87.49bn to 103.35bn while net income improved 49.23% from 12.82bn to 19.13bn.
Gross margin | 70.48% |
---|---|
Net profit margin | 19.41% |
Operating margin | 20.89% |
Return on assets | 17.05% |
---|---|
Return on equity | 22.27% |
Return on investment | 21.79% |
More ▼
Cash flow in INRView more
In 2024, Mankind Pharma Ltd increased its cash reserves by 25.32%, or 771.87m. The company earned 21.52bn from its operations for a Cash Flow Margin of 20.83%. In addition the company generated 52.66m cash from financing while 20.82bn was spent on investing.
Cash flow per share | 63.95 |
---|---|
Price/Cash flow per share | 39.95 |
Book value per share | 263.69 |
---|---|
Tangible book value per share | 222.76 |
More ▼
Balance sheet in INRView more
Current ratio | 2.95 |
---|---|
Quick ratio | 2.37 |
Total debt/total equity | 0.0456 |
---|---|
Total debt/total capital | 0.0428 |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 49.01%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 35.63 |